QBD approach in HPLC method development and validation of furazolidone
School of Pharmacy, Dr. A.P.J. Abdul Kalam University, Indore, India.
Research Article
World Journal of Biology Pharmacy and Health Sciences, 2024, 18(03), 027–030.
Article DOI: 10.30574/wjbphs.2024.18.3.0316
Publication history:
Received on 22 April 2024; revised on 29 May 2024; accepted on 31 May 2024
Abstract:
QbD principles for establishment of a HPLC method for Furazolidone with improved robustness and performance. On the basis of the initial prioritization and factor screening studies, the highly influential factors were identified and subsequently optimized for improving the method robustness. The response surface mapping particularly facilitated improved understanding of the factor–response relationship and interactions associated with them. Extensive validation studies further ensured high degree of method robustness with extreme variation in the key variables influencing the method performance. In addition, the method showed improved sensitivity for the Furazolidone much beyond the values reported in the literature.
Keywords:
QbD; Validation; Furazolidone; Robustness; Frequency
Full text article in PDF:
Copyright information:
Copyright © 2024 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0